Genetic discovery reveals key to inflammatory diseases

FHS
June 7, 2024
4:15 am

Researchers discovered that a specific haplotype on chromosome 21 is linked to five inflammatory diseases, offering insights into potential new treatments.

TAVR’s Win in Women; Chest Pressure During Cardioversion; Doc Goes to Space

The RHEIA trial, which found transcatheter aortic valve replacement (TAVR) superior to surgery for women, was among the highlights of the European Society of Cardiology

September 4, 2024

Alector Therapeutics’ novel Alzheimer’s strategy fails in Phase 2 trial

Alector Therapeutics said Monday that its Phase 2 trial for an experimental Alzheimer’s antibody failed, dealing a blow to what had been one of the

November 25, 2024

Researchers propose a ‘protein aggregation clock’ to measure aging and health

Could measuring protein clumps in our cells be a new way to find out our risk of getting age-related diseases? Professor Dorothee Dormann and Professor

June 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.